Morgan Stanley Sanara Med Tech Inc. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Morgan Stanley holds 7,236 shares of SMTI stock, worth $218,165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,236
Previous 8,288
12.69%
Holding current value
$218,165
Previous $306,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SMTI
# of Institutions
39Shares Held
739KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$5.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$4.39 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA84.5KShares$2.55 Million0.0% of portfolio
-
Janney Montgomery Scott LLC56.2KShares$1.69 Million0.0% of portfolio
-
State Street Corp Boston, MA53.8KShares$1.62 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $250M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...